MedPath

CSOP SEA TECH ETF(USD)

🇴🇲Oman
Ownership
-
Established
1986-01-01
Employees
-
Market Cap
-
Website
http://www.squ.edu.om

Clinical Trials

46

Active:1
Completed:19

Trial Phases

6 Phases

Early Phase 1:2
Phase 1:1
Phase 2:3
+3 more phases

Drug Approvals

0

Drug Approvals

No drug approvals found

This company may not have drug approvals in our database

Clinical Trials

Distribution across different clinical trial phases (37 trials with phase data)• Click on a phase to view related trials

Not Applicable
22 (59.5%)
Phase 4
5 (13.5%)
Phase 3
4 (10.8%)
Phase 2
3 (8.1%)
Early Phase 1
2 (5.4%)
Phase 1
1 (2.7%)

Effect of Smartphone Application (MED-AD) on Medication Adherence Among Patients With Cardiovascular Disease in Oman

Not Applicable
Not yet recruiting
Conditions
Ischemic Cardiovascular Disease
Hypertension
Hyperlipidemia
First Posted Date
2025-04-30
Last Posted Date
2025-04-30
Lead Sponsor
Sultan Qaboos University
Target Recruit Count
1000
Registration Number
NCT06951451
Locations
🇴🇲

Ministry of Health, Muscat, Oman

Enhancing Life Quality in Community-Dwelling Older Omanis by Telling Their Life Story

Not Applicable
Completed
Conditions
Healthy Older Adults
First Posted Date
2025-03-18
Last Posted Date
2025-03-24
Lead Sponsor
Sultan Qaboos University
Target Recruit Count
75
Registration Number
NCT06881914
Locations
🇴🇲

Sultan Qaboos University Hospital, Muscat, Oman

Effective of Transcranial Magnetic Stimulation (TMS) vs Treatment as Usual for First-Episode Depression in Adults

Phase 4
Not yet recruiting
Conditions
Major Depressive Disorder
Interventions
Device: Transcranial magnetic stimulation
First Posted Date
2024-10-16
Last Posted Date
2024-10-28
Lead Sponsor
Sultan Qaboos University
Target Recruit Count
120
Registration Number
NCT06644833

Central Venous Catheter-Related Thrombosis in Critically Ill Patients

Completed
Conditions
Catheter Related Complication
First Posted Date
2024-08-27
Last Posted Date
2025-05-18
Lead Sponsor
Sultan Qaboos University
Target Recruit Count
315
Registration Number
NCT06573112
Locations
🇴🇲

Sultan Qaboos University Hospital, Muscat, Oman

The Use of Melatonin for Delirium Prevention in Medically Hospitalized Patients

Phase 2
Recruiting
Conditions
Delirium
Interventions
Drug: Intervention 2
Drug: Intervention 1
Other: Control
First Posted Date
2024-07-19
Last Posted Date
2025-01-14
Lead Sponsor
Sultan Qaboos University
Target Recruit Count
240
Registration Number
NCT06509191
Locations
🇴🇲

Sultan Qaboos University Hospital, Muscat, Oman

  • Prev
  • 1
  • 2
  • 3
  • 4
  • 5
  • 8
  • Next

News

Oman Achieves Medical Milestone with First Successful CAR-T Cell Therapy Implementation

The University Medical City in Oman successfully implemented the first CAR-T cell therapy in the Sultanate, positioning the country among regional leaders in advanced blood cancer treatment.

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.